Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03504033

Xenon-anesthesia on Patients Undergoing Major Liver-resection

Xenon-anesthesia on Patients Undergoing Major Liver-resection: Randomized Controlled Trial

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
RWTH Aachen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the postoperative outcome of patients undergoing major liver resection under xenon- compared to desflurane-anesthesia.

Detailed description

The aim of this study is to compare the postoperative liver function and additional outcome parameters of patients undergoing major liver resection under xenon- compared to desflurane-anesthesia. Xenon is known to maintain hemodynamic stability and consecutive tissue perfusion. Together with its potential for ischemic pre-conditioning, we hypothesize a protective effect of xenon on post-operative liver failure and ischemia/reperfusion injury.

Conditions

Interventions

TypeNameDescription
DRUGXenoninhalation to maintain anesthesia
DRUGDesfluraneinhalation to maintain anesthesia

Timeline

Start date
2018-04-11
Primary completion
2019-09-27
Completion
2019-09-27
First posted
2018-04-20
Last updated
2019-10-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03504033. Inclusion in this directory is not an endorsement.